Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 4 of 18 for:    cu-64

PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer (Cu-64 HER2+)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00605397
Recruitment Status : Completed
First Posted : January 31, 2008
Last Update Posted : December 28, 2015
Sponsor:
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : December 2013